Pavol Fülöp

Dr. Pavol Fülöp


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2023 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
PFPavol Fülöp
Pavol Fülöp
GVGabriel Valocik
Gabriel Valocik
MVMarianna Barbierik Vachalcova
Marianna Barbierik Vachalcova
PZPavol Zenuch
Pavol Zenuch
LFLenka Filipova
Lenka Filipova
At the present time, right ventricular function in patients with aortic stenosis is insufficiently taken into account in the decision-making process of aortic valve replacement. The aim of our study was to evaluate significance of right ventricular dysfunction in patients with severe aortic stenosis by modern 3D echocardiographic methods. This is prospective analysis of 68 patients with severe high and low-gradient aortic stenosis. We evaluated function of left and right ventricle on the basis of 3D reconstruction. Enddiastolic, endsystolic volumes, ejection fraction and stroke volumes of both chambers were assessed. There were more patients with right ventricular dysfunction in low-gradient group (RVEF < 45%) than in the high-gradient group (63.6% vs 39%, p = 0.02). Low-gradient patients had worse right ventricular function than high-gradient patients (RVEF 36% vs 46%, p = 0.02). There wasn’t any significant correlation between the right ventricular dysfunction and pulmonary hypertension (r = − 0.25, p = 0.036). There was significant correlation between left and right ejection fraction (r = 0.78, p < 0.0001). Multiple regression analysis revealed that the only predictor of right ventricular function is the left ventricular function. According to our results we can state that right ventricular dysfunction is more common in patients with low-gradient than in high-gradient aortic stenosis and the only predictor of right ventricular dysfunction is left ventricular dysfunction, probably based on ventriculo-ventricular interaction. Pulmonary hypertension in patients with severe AS does not predict right ventricular dysfunction.

14 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PFPavol Fülöp
Pavol Fülöp
ŠTŠtefan Tóth
Štefan Tóth
TPTibor Poruban
Tibor Poruban
ZFZuzana Fülöpová
Zuzana Fülöpová
ABAnna Borovská
Anna Borovská
MDMariana Dvoroznakova
Mariana Dvoroznakova
Background: Despite the availability of direct oral anticoagulants, warfarin remains essential for mechanical valves, renal impairment, and resource-limited settings. Traditional dosing achieves therapeutic range in only 55–65% of patients, increasing bleeding and thrombotic complications. This systematic review evaluates the literature on machine learning (ML) approaches for warfarin dose prediction (2022–2025). Methods: We analysed 14 studies encompassing 122,400 patients across nine countries following PRISMA guidelines. Studies utilizing ML algorithms for warfarin dosing with quantifiable performance metrics were included. Risk of bias was assessed using PROBAST. Results: Reinforcement learning demonstrated superior performance, achieving an 80.8% excellent responder ratio versus 41.6% for standard practice and 99.5% safety responder ratio versus 83.1%. Support vector machines achieved R2 up to 0.98 in homogeneous populations. Mean absolute error ranged from 0.11 to 1.8 mg/day, consistently outperforming traditional methods. Seven studies included external validation, whilst 78.6% were retrospective designs. Limited implementation studies showed therapeutic INR rates improving from 47.5% to 61.1%. Critically, only three studies (21.4%) reported any safety outcomes, with none adequately powered to detect differences in major bleeding events. Conclusions: While ML algorithms demonstrate improved dosing accuracy in retrospective analyses, the near-complete absence of adequately powered safety outcome data represents the primary barrier to clinical implementation. Without robust evidence on bleeding, thromboembolism, and mortality, the risk–benefit profile remains unknown. Implementation requires addressing: the predominance of retrospective studies (78.6%), limited prospective validation, restricted geographic diversity (43% from China), absence of African and South American studies, and no new Hispanic population data. Multicentre prospective trials with safety endpoints, population-specific validation, and interpretable models are essential before widespread clinical adoption can be recommended.

1 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ŠTŠtefan Tóth
Štefan Tóth
MVMarianna Vachalcova
Marianna Vachalcova
KBKamil Barbierik
Kamil Barbierik
AJAdriana Jarolimkova
Adriana Jarolimkova
PFPavol Fülöp
Pavol Fülöp
TPTibor Poruban
Tibor Poruban
Background/Objectives: Cardiovascular (CV) diseases remain the leading cause of morbidity and mortality across Europe. Despite substantial progress in prevention, diagnostics, and therapeutics, outpatient cardiology care continues to face systemic challenges, including limited consultation time, workforce constraints, and incomplete clinical information at the point of care. The primary objective of this study is threefold. First, to evaluate whether AI-enhanced telemedicine improves clinical control of hypertension, dyslipidemia, and heart failure compared to standard ambulatory care. Second, to assess the impact on physician workflow efficiency and documentation burden through AI-assisted clinical documentation. Third, to determine patient satisfaction and safety profiles of integrated telemedicine–AI systems. Clinical control will be measured by a composite endpoint of disease-specific targets assessed at the 12-month follow-up visit. Methods: The TeleAI-CVD Concept Study aims to evaluate the integration of telemedicine and artificial intelligence (AI) to enhance the efficiency, quality, and individualization of cardiovascular disease management in the ambulatory setting. Within this framework, AI-driven tools will be employed to collect structured clinical histories and current symptomatology from patients prior to outpatient visits using digital questionnaires and conversational interfaces. Results: Obtained data, combined with telemonitoring metrics, laboratory parameters, and existing clinical records, will be synthesized to support clinical decision-making. Conclusions: This approach is expected to streamline consultations, increase diagnostic accuracy, and enable personalized, data-driven care through continuous evaluation of patient trajectories. The anticipated outcomes of the TeleAI-CVD study include the development of optimized, AI-assisted management protocols for cardiology patients, a reduction in unnecessary in-person visits through effective telemedicine-based follow-up, and accelerated attainment of therapeutic targets. Ultimately, this concept seeks to redefine the paradigm of outpatient cardiovascular care by embedding advanced digital technologies within routine clinical workflows.

27 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ABAlžbeta Bánovčinová
Alžbeta Bánovčinová
ISIngrid Schusterova
Ingrid Schusterova
ŠTŠtefan Tóth
Štefan Tóth
TPTibor Poruban
Tibor Poruban
DPDominik Pella
Dominik Pella
PFPavol Fülöp
Pavol Fülöp
Background: Childhood obesity demonstrates substantial metabolic heterogeneity. We determined insulin resistance prevalence in Slovak children with obesity using multiple validated markers and identified high-risk phenotypes. Methods: Cross-sectional study of 54 obese children (BMI 29.5 ± 4.7 kg/m2) and 33 controls (BMI 20.6 ± 1.9 kg/m2). All underwent bioelectrical impedance analysis and fasting metabolic profiling, including HOMA-IR and triglyceride-to-HDL cholesterol (TG/HDL-C) ratio. Insulin resistance was defined as HOMA-IR > 3.42 (obese) or >1.68 (controls), and TG/HDL-C > 0.99 mmol/L. Age-matched sensitivity analysis was performed on 28 pairs. Results: Among obese children, 44.4% demonstrated HOMA-IR-defined insulin resistance versus 45.5% of controls using respective cut-offs, with significantly higher mean HOMA-IR (3.66 ± 2.09 vs. 2.53 ± 2.59, p = 0.034). Age-matched analysis (n = 28 pairs, mean age difference 0.22 years) confirmed these findings with HOMA-IR 3.46 ± 2.18 vs. 2.27 ± 2.22 (p = 0.0271). The TG/HDL-C ratio identified insulin resistance in 38.9% of obese versus 12.1% of controls. Critically, 22.2% of obese children showed concordant elevation of both markers (vs. 6.1% controls; OR 4.43); in age-matched analysis, this difference was even more pronounced (17.9% vs. 3.6%). Low skeletal muscle mass (40%) characterized 22.6% of obese children, demonstrating 91.7% insulin resistance prevalence versus 31.0% without low muscle mass (p < 0.001), with HOMA-IR 1.9 points higher (95% CI: 0.31–2.73). Remarkably, 50% of children with low muscle mass showed concordant elevation of both metabolic markers versus 14.3% without (OR 6.0). Conclusions: Low skeletal muscle mass in obese Slovak children represents a very-high-risk phenotype with 91.7% insulin resistance prevalence and 6-fold increased odds of severe metabolic dysfunction. Age-matched analysis confirmed that metabolic differences are independent of age effects. Body composition-based risk stratification enables personalized interventions targeting the highest-risk children.

14 December 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
KUKarolina Angela Sieradzka Uchnar
Karolina Angela Sieradzka Uchnar
ISIngrid Schusterova
Ingrid Schusterova
ŠTŠtefan Tóth
Štefan Tóth
TPTibor Poruban
Tibor Poruban
MDMariana Dvoroznakova
Mariana Dvoroznakova
PFPavol Fülöp
Pavol Fülöp
Objective: This study aims to analyze relationships between body composition, biochemical parameters, and cardiac function in young adults to identify mechanisms of cardiac dysfunction in obesity. Methods: This is a cross-sectional study of 60 young adults (mean age 20.4 years) divided into healthy (n = 29) and overweight/obese (n = 31) groups. Body composition was assessed using bioelectrical impedance analysis. We calculated the SMM-to-Fat ratio (skeletal muscle mass %/body fat %) as a continuous composite metric. Cardiac function was evaluated using 3D speckle-tracking echocardiography, with a 3D global circumferential strain pre-specified as the primary endpoint. Results: The obese group showed unfavorable body composition with lower SMM% (38.0 ± 10.8 vs. 47.1 ± 5.6%), higher body fat% (28.3 ± 12.6 vs. 16.0 ± 8.3%), and lower SMM-to-Fat ratio (2.1 ± 2.3 vs. 4.8 ± 5.1; all p < 0.001). C-peptide was 75% higher (p < 0.001), indicating compensatory hyperinsulinemia. The primary endpoint showed impairment in the obese group (−19.8 ± 4.7 vs. −22.2 ± 2.9%; p = 0.023, d = 0.61), while longitudinal strain was preserved, indicating selective mid-wall dysfunction. The SMM-to-Fat ratio demonstrated a stronger association with circumferential strain (r = −0.467, p = 0.008) than SMM% alone (r = −0.414, p = 0.021) and remained an independent predictor in multivariable analysis (β = −0.88, p = 0.019), whereas SMM% did not achieve significance (p = 0.159). Comprehensive analysis revealed correlation reversal across all body composition parameters between groups, with minerals% and total body water% emerging as additional independent predictors. Conclusions: Young obese adults exhibit selective mid-wall cardiac dysfunction. The SMM-to-Fat ratio, representing muscle–adiposity balance, is superior to SMM% alone for predicting cardiac dysfunction. Our findings suggest that the relative balance, rather than absolute muscle mass, determines cardiac health in obesity, with implications for body composition assessment and intervention strategies.

27 October 2025 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
STStefan Toth
Stefan Toth
AJAdriana Jarolimkova
Adriana Jarolimkova
PBPatrik Bucek
Patrik Bucek
MSMartin Sevcik
Martin Sevcik
PFPavol Fülöp
Pavol Fülöp
TPTibor Poruban
Tibor Poruban
Background and objectives: Numerous studies and meta-analyses have established the efficacy of telemonitoring for blood pressure and other components of metabolic syndrome in improving disease management. Nevertheless, the adoption of telemonitoring technologies is often hindered by personal, technological, and systemic barriers. In Slovakia, where patient–physician contact rates are high, there is limited research on patients’ perspectives regarding telemedicine adoption for cardiovascular risk management. The objective of this study was to examine patients’ perspectives on and perceived obstacles to the use of telemonitoring for arterial hypertension and dyslipidemia in Slovakia. Methods: This cross-sectional, questionnaire-based survey targeted a cohort of 18,053 patients. The survey instrument was designed to gather data on several key areas: patient demographic characteristics, blood pressure measurement habits, the utilization of smart technologies, perceived benefits and barriers to telemonitoring, and patients’ knowledge of their lipid profiles and cardiovascular risk factors. Statistical analysis included chi-square tests, ANOVA, and effect size calculations with 95% confidence intervals (CI). Results: A total of 1787 patient responses (9.9%) were collected. Among the respondents, 67.4% (n = 1204) had arterial hypertension, while 7.9% (n = 95) were on non-pharmacological therapy. Only 21.2% (n = 255) of hypertensive patients measured their blood pressure daily, with a significantly higher proportion of men than women (28.6% vs. 12.7%, p = 0.011, Cohen’s d = 0.42). The most frequent users of blood pressure monitoring were in the 31–45 age group (p = 0.001, η2 = 0.08). A total of 19.4% (n = 347) of respondents used wearable devices, and 6.3% (n = 113) used blood pressure monitors connected to an application. Smart technology use was significantly more common in the 31–45 age group (p = 0.01, Cramer’s V = 0.15). Moderate interest in telemedicine was expressed by 69.8% (n = 1247) of respondents, though only 27.4% (n = 490) showed strong interest. The majority of patients (73.8%, n = 1319) did not know their LDL-C levels, and 45.7% (n = 817) of those who did had elevated levels. Conclusions: The findings suggest that while interest in telemedicine methods for the management of arterial hypertension and dyslipidemia exists among Slovak patients, it is more moderate than initially assumed. Importantly, expressed willingness to participate in a study should not be directly equated with readiness to adopt new technologies in daily practice. Successful integration of telemonitoring into the Slovak healthcare system will therefore require not only patient engagement but also active support from healthcare providers to overcome practical and motivational barriers. These findings highlight the need for targeted implementation strategies that address the specific barriers identified in the Central and Eastern European healthcare context.